相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。JAK inhibition as a therapeutic strategy for immune and inflammatory diseases (vol 16, pg 843, 2017)
Daniella M. Schwartz et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity
Ioannis Mitroulis et al.
CELL (2018)
Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis
Marit Westerterp et al.
CIRCULATION (2018)
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
Paul M. Ridker et al.
LANCET (2018)
Development of a prognostically relevant cachexia index in primary myelofibrosis using serum albumin and cholesterol levels
Ayalew Tefferi et al.
BLOOD ADVANCES (2018)
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
S. Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study
Claire N. Harrison et al.
LANCET HAEMATOLOGY (2017)
LNK/SH2B3 Loss of Function Promotes Atherosclerosis and Thrombosis
Wei Wang et al.
CIRCULATION RESEARCH (2016)
Enhanced Megakaryopoiesis and Platelet Activity in Hypercholesterolemic, B6-Ldlr-/-, Cdkn2a-Deficient Mice
Wei Wang et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2016)
Disordered haematopoiesis and athero-thrombosis
Andrew J. Murphy et al.
EUROPEAN HEART JOURNAL (2016)
Enhanced Megakaryopoiesis and Platelet Activity in Hypercholesterolemic, B6-Ldlr-/-, Cdkn2a-Deficient Mice
Wei Wang et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2016)
Interleukin-3/Granulocyte Macrophage Colony-Stimulating Factor Receptor Promotes Stem Cell Expansion, Monocytosis, and Atheroma Macrophage Burden in Mice With Hematopoietic ApoE Deficiency
Mi Wang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Critical Role of Jak2 in the Maintenance and Function of Adult Hematopoietic Stem Cells
Hajime Akada et al.
STEM CELLS (2014)
Hypercholesterolemia and reduced HDL-C promote hematopoietic stem cell proliferation and monocytosis: Studies in mice and FH children
Sonia Tolani et al.
ATHEROSCLEROSIS (2013)
Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis
Andrew J. Murphy et al.
NATURE MEDICINE (2013)
Conditional Deletion of Jak2 Reveals an Essential Role in Hematopoiesis throughout Mouse Ontogeny: Implications for Jak2 Inhibition in Humans
Sung O. Park et al.
PLOS ONE (2013)
Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities
Ira Tabas et al.
SCIENCE (2013)
Extramedullary Hematopoiesis Generates Ly-6Chigh Monocytes That Infiltrate Atherosclerotic Lesions
Clinton S. Robbins et al.
CIRCULATION (2012)
CD11c/CD18 Expression Is Upregulated on Blood Monocytes During Hypertriglyceridemia and Enhances Adhesion to Vascular Cell Adhesion Molecule-1
R. Michael Gower et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice
Andrew J. Murphy et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Safety and Efficacy of TG101348, a Selective JAK2 Inhibitor, in Myelofibrosis
Animesh Pardanani et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Hyperlipidemia-Triggered Neutrophilia Promotes Early Atherosclerosis
Maik Drechsler et al.
CIRCULATION (2010)
Severe hypocholesterolaemia is often neglected in haematological malignancies
Luca Pugliese et al.
EUROPEAN JOURNAL OF CANCER (2010)
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Peter Duewell et al.
NATURE (2010)
Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis.
Srdan Verstovsek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Leukocytosis as a predictor for non-infective mortality and morbidity
K. Asadollahi et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2010)
ATP-Binding Cassette Transporters and HDL Suppress Hematopoietic Stem Cell Proliferation
Laurent Yvan-Charvet et al.
SCIENCE (2010)
High-Density Lipoprotein Reduces the Human Monocyte Inflammatory Response
Andrew J. Murphy et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera
Gerlinde Werning et al.
CANCER CELL (2008)
Role of the JAK/STAT pathway in the regulation of interleukin-8 transcription by oxidized phospholipids in vitro and in atherosclerosis in vivo
Nima M. Gharavi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Ly-6C(hi) monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata
Filip K. Swirski et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques
Frank Tacke et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders
Ross L. Levine et al.
NATURE REVIEWS CANCER (2007)
X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and NIMM patients with clonal hematopoiesis
Ross L. Levine et al.
BLOOD (2006)
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
RL Levine et al.
CANCER CELL (2005)
Leukocytosis and ischemic vascular disease morbidity and mortality - Is it time to intervene?
BS Coller
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Efficacy and safety of low-dose aspirin in polycythemia vera
R Landolfi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
分享论文
